Showing results (371-380 of 558) with videos related to

Sort By:
Pageof 56
Optics Express|July 30, 2025
High-Q chiral metasurfaces with in-plane symmetric C-point engineering for nonlinear circular dichroismHao Chen, Xiao Chen, Haoshuang Zhong, et al.
European Journal of Medicinal Chemistry|August 26, 2021
Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitorsYue Ma, Shujie Zhao, Yujie Ren, et al.
European Journal of Medicinal Chemistry|July 24, 2025
Further exploring the tolerant region II: Identification of 2,4,5-trisubstituted pyrimidines as HIV-1 reverse transcriptase allosteric inhibitors with desirable antiviral activities and reduced cytotoxicityZhenzhen Zhou, Lin Zheng, Wenbo Jiang, et al.
Signal Transduction and Targeted Therapy|December 29, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signalingYi Zheng, Meng-Wei Zhuang, Lulu Han, et al.
Open Life Sciences|March 10, 2025
High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathwayTian-Wen Qiu, Zhan Jin, Zhi-Zhan Fu, et al.
European Journal of Medicinal Chemistry|August 2, 2024
Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBPZhenzhen Zhou, Yanying Sun, Yanyang Qin, et al.
Bioorganic Chemistry|August 31, 2025
Design, synthesis, and biological evaluation of dual-site HIV-1 inhibitors simultaneously targeting the NNRTI binding pocket and an adjacent site with favorable resistance profilesXiangkai Ji, Xiangyi Jiang, Xing Huang, et al.
Journal of Medical Virology|October 6, 2016
A cell-based high-throughput protocol to screen entry inhibitors of highly pathogenic viruses with Traditional Chinese MedicinesYong Yang, Han Cheng, Hui Yan, et al.
Journal of Medicinal Chemistry|February 28, 2024
Structure-Based Design of Novel G-Protein-Coupled Receptor TAAR1 Agonists as Potential Antipsychotic Drug CandidatesZhenzhen Zhou, Weifeng Zhang, Fabao Zhao, et al.
Journal of Medical Virology|March 7, 2024
Structure-based design of diarylpyrimidines and triarylpyrimidines as potent HIV-1 NNRTIs with improved metabolic stability and drug resistance profilesMinghui Xie, Zhao Wang, Fabao Zhao, et al.
Pageof 56